Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double-Blind, Double-Dummy, Randomized, Placebo-Controlled, 2-Arm, 2X2 Crossover Study Comparing the Effects of Montelukast, Inhaled Budesonide, and Placebo on Lower Leg Growth in Children (Prepubertal, Tanner Stage I) With Mild Asthma

NCT00092092 is registered in ClinicalTrials.gov with Organon and Co as lead sponsor.

NCT NCT00092092
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00092092 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double-Blind, Double-Dummy, Randomized, Placebo-Controlled, 2-Arm, 2X2 Crossover Study Comparing the Effects of Montelukast, Inhaled Budesonide, and Placebo on Lower Leg Growth in Children (Prepubertal, Tanner Stage I) With Mild Asthma
Lead sponsor
Organon and Co
Phase
Phase 4
Overall status
Completed
Start date
October 31, 2002
Completion date
June 30, 2004
Enrollment
71 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

asthma, bronchial